World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33472196

Number of visits today: 1841

Number of downloads: 16655900

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Noorulla K, Yasir M, Muzaffar F, S R, Ghoneim MM, Almurshedi AS, Tura AJ, Alshehri S, Gebissa T, Mekit S, Ahmed MM, Zafar A. Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting: Formulation development, optimization and In-Vivo preclinical evaluation. Journal of Drug Delivery Science and Technology 2022;67:102939. [DOI: 10.1016/j.jddst.2021.102939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]

For:

Noorulla K, Yasir M, Muzaffar F, S R, Ghoneim MM, Almurshedi AS, Tura AJ, Alshehri S, Gebissa T, Mekit S, Ahmed MM, Zafar A. Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting: Formulation development, optimization and In-Vivo preclinical evaluation. Journal of Drug Delivery Science and Technology 2022;67:102939. [DOI: 10.1016/j.jddst.2021.102939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]

Number	Citing Articles
1	Marcello E, Chiono V. Biomaterials-Enhanced Intranasal Delivery of Drugs as a Direct Route for Brain Targeting. Int J Mol Sci 2023;24. [PMID: 36834804 DOI: 10.3390/ijms24043390] [Reference Citation Analysis]
2	Vasilieva EA, Kuznetsova DA, Valeeva FG, Kuznetsov DM, Zakharov AV, Amerhanova SK, Voloshina AD, Zueva IV, Petrov KA, Zakharova LY. Therapy of Organophosphate Poisoning via Intranasal Administration of 2-PAM-Loaded Chitosomes. Pharmaceutics 2022;14. [PMID: 36559339 DOI: 10.3390/pharmaceutics14122846] [Reference Citation Analysis]
3	Correia AC, Monteiro AR, Silva R, Moreira JN, Sousa Lobo JM, Silva AC. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders. Adv Drug Deliv Rev 2022;189:114485. [PMID: 35970274 DOI: 10.1016/j.addr.2022.114485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4	de Barros C, Portugal I, Batain F, Portella D, Severino P, Cardoso J, Arcuri P, Chaud M, Alves T. Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems. RPS Pharmacy and Pharmacology Reports 2022;1. [DOI: 10.1093/rpsppr/rqac003] [Reference Citation Analysis]
5	Zaki RM, Aldawsari MF, Alossaimi MA, Alzaid SF, Devanathadesikan Seshadri V, Almurshedi AS, Aldosari BN, Yusif RM, Sayed OM. Brain Targeting of Quetiapine Fumarate via Intranasal Delivery of Loaded Lipospheres: Fabrication, In-Vitro Evaluation, Optimization, and In-Vivo Assessment. Pharmaceuticals 2022;15:1083. [DOI: 10.3390/ph15091083] [Reference Citation Analysis]
6	Nguyen T, Duong V. Solid Lipid Nanoparticles. Encyclopedia 2022;2:952-73. [DOI: 10.3390/encyclopedia2020063] [Reference Citation Analysis]